Thompson Siegel & Walmsley LLC Has $73.21 Million Position in Perrigo Company plc (NYSE:PRGO)

Thompson Siegel & Walmsley LLC cut its position in Perrigo Company plc (NYSE:PRGO) by 6.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,847,434 shares of the company’s stock after selling 210,385 shares during the quarter. Perrigo accounts for about 1.1% of Thompson Siegel & Walmsley LLC’s portfolio, making the stock its 23rd largest holding. Thompson Siegel & Walmsley LLC’s holdings in Perrigo were worth $73,208,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Atria Investments Inc acquired a new position in Perrigo during the 3rd quarter worth approximately $208,000. Venturi Wealth Management LLC bought a new stake in Perrigo during the 3rd quarter worth approximately $56,000. Victory Capital Management Inc. grew its holdings in Perrigo by 1.2% during the 3rd quarter. Victory Capital Management Inc. now owns 1,422,288 shares of the company’s stock worth $37,307,000 after acquiring an additional 16,735 shares during the last quarter. KBC Group NV grew its holdings in Perrigo by 25.1% during the 3rd quarter. KBC Group NV now owns 4,517 shares of the company’s stock worth $118,000 after acquiring an additional 905 shares during the last quarter. Finally, Nicola Wealth Management LTD. grew its holdings in Perrigo by 59.0% during the 3rd quarter. Nicola Wealth Management LTD. now owns 159,000 shares of the company’s stock worth $4,171,000 after acquiring an additional 59,000 shares during the last quarter. 95.91% of the stock is currently owned by institutional investors and hedge funds.

Perrigo Stock Down 1.4 %

Perrigo stock opened at $27.50 on Thursday. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94. Perrigo Company plc has a 12-month low of $23.14 and a 12-month high of $33.46. The firm’s fifty day moving average is $25.38 and its 200 day moving average is $26.22. The company has a market capitalization of $3.75 billion, a PE ratio of -23.50 and a beta of 0.48.

Perrigo (NYSE:PRGO) last released its quarterly earnings data on Thursday, February 27th. The company reported $0.93 earnings per share for the quarter, topping the consensus estimate of $0.92 by $0.01. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The firm had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.20 billion. As a group, sell-side analysts predict that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Perrigo Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Shareholders of record on Friday, March 7th will be issued a dividend of $0.29 per share. This is an increase from Perrigo’s previous quarterly dividend of $0.28. The ex-dividend date of this dividend is Friday, March 7th. This represents a $1.16 annualized dividend and a yield of 4.22%. Perrigo’s dividend payout ratio is presently -92.80%.

Insiders Place Their Bets

In related news, EVP Ronald Craig Janish sold 7,800 shares of the stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $27.44, for a total transaction of $214,032.00. Following the completion of the transaction, the executive vice president now owns 33,666 shares in the company, valued at approximately $923,795.04. This represents a 18.81 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on PRGO. StockNews.com lowered shares of Perrigo from a “buy” rating to a “hold” rating in a report on Wednesday, February 19th. Piper Sandler lowered shares of Perrigo from an “overweight” rating to a “neutral” rating and reduced their price objective for the company from $34.00 to $27.00 in a research note on Monday, January 6th. Finally, Argus lowered shares of Perrigo from a “buy” rating to a “hold” rating in a research note on Tuesday, January 14th. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $33.00.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.